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Abstract
Objective: Gait impairment is common in patients with cerebral small vessel
disease (SVD). However, gait studies in elderly SVD patients might be con-
founded by age-related comorbidities, such as polyneuropathy or sarcopenia.
We therefore studied young patients with the genetically defined SVD CADA-
SIL. Our aim was to examine the effects of pure SVD on single and dual task
gait, and to investigate associations of gait performance with cognitive deficits
and white matter alterations. Methods: We investigated single task walking and
calculatory, semantic, or motoric dual task costs in 39 CADASIL patients (mean
age 50  8) using a computerized walkway. We obtained 3.0T MRI and neu-
ropsychological data on processing speed, the main cognitive deficit in CADA-
SIL. Spatiotemporal gait parameters were standardized based on data from 192
healthy controls. Associations between white matter integrity, assessed by diffu-
sion tensor imaging, and gait were analyzed using both a global marker and
voxel-wise analysis. Results: Compared to controls, CADASIL patients showed
only mild single task gait impairment, and only in the rhythm domain. The
semantic dual task additionally uncovered mild deficits in the pace domain.
Processing speed was not associated with gait. White matter alterations were
related to single task stride length but not to dual task performance. Interpreta-
tion: Despite severe disease burden, gait performance in patients with pure
small vessel disease was relatively preserved in single and dual tasks. Results
suggest that age-related pathologies other than small vessel disease might play a
role for gait impairment in elderly SVD patients.
Introduction
Gait impairment and cognitive deficits are common
symptoms in cerebral small vessel disease (SVD) and a
major cause of loss of independence.1,2 For mobility capa-
bilities, both symptoms bear a high risk for falls and frac-
tures, specifically in the elderly.3 Senile, vascular gait
impairment in sporadic SVD patients has been character-
ized by a reduction in gait velocity,4–8 reduction in stride
length,4,6,7 and increased double support times.4,6 How-
ever, the etiology of gait impairment in SVD is still
debated. The traditional view holds that lesions in strate-
gic white matter tracts have a detrimental effect on
supraspinal locomotor control.4,6,9,10 This view is
challenged by studies showing that gait control can also
be affected by age-related instability due to degenerative
musculoskeletal impairments, for example, joint prob-
lems, sarcopenia, or polyneuropathy.3 A complementary
view is that cognitive deficits are a major cause of gait
disturbances and falls.11 The notion is based on experi-
ments using cognitive dual-tasking, in which participants
perform an attention-demanding task while walking.12
Gait performance deteriorates under this condition in
healthy subjects13 and especially in cognitively impaired
subjects.14–18 The underlying hypothesis is that walking,
that is, planning and execution of movements, postural
control, motor coordination, and the secondary cognitive
task compete for the same limited cognitive resources.
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While gait difficulties can be cognitively compensated
during single task walking, this compensation mechanism
is disrupted or limited by a secondary cognitive task.
Thus, dual task walking can pronounce or even uncover
gait deficits that are not obvious while walking only.3,18
Results of previous studies on gait impairment in SVD
are based on sporadic SVD patients or individuals with
mild cognitive impairment (MCI) aged 60 years or
older.4,6,7,9,10,18,19 A potentially crucial limitation of these
studies is the confounding by age-related co-pathologies,
such as affected biomechanics, sarcopenia, or disturbed
sensory feedback (vision, proprioception). One approach
to overcome these limitations is to explore the effect of
dual-tasking on gait in a model disease of pure SVD
without confounding pathology. We therefore studied
patients with cerebral autosomal dominant arteriopathy
with subcortical infarcts and leukoencephalopathy
(CADASIL), a genetically defined, pure form of SVD.
CADASIL is characterized by an early disease onset
between 35 and 50 years.1 Conditions typically impacting
on gait performance in elderly subjects, such as muscu-
loskeletal constraints, joint abrasion, polyneuropathy, Alz-
heimer-type changes, or other neurodegenerative
pathology,20 and normal pressure hydrocephalus21 are
uncommon in CADASIL patients.
SVD-related white matter alterations can be assessed
using diffusion tensor imaging (DTI). DTI scalar mea-
sures are sensitive markers for SVD progression22 and
show a stronger association with gait decline than con-
ventional SVD markers, such as white matter hyperinten-
sities (WMH), lacunes, and microbleeds.9
The aim of the present study was to investigate the
effect of pure SVD on single task and dual task walking.
We hypothesized that (1) gait impairment in pure SVD
would be most evident while dual task walking, (2) there
is an association between processing speed, the main cog-
nitive deficit in SVD, and gait, and (3) SVD-related white
matter alterations (as assessed by DTI) are associated with
gait performance.
To our knowledge, this is the first study analyzing spa-
tiotemporal gait data in patients with pure SVD. Here, we
combine most recent methods of gait recording, diffusion
tensor imaging and analysis.
Methods
Subjects
We included 39 CADASIL patients from an ongoing,
prospective single-center study in Munich, Germany.
CADASIL was confirmed by either molecular genetic test-
ing (sequencing of the NOTCH3 gene) or by ultrastruc-
tural analysis of a skin biopsy (detection of
pathognomonic granular osmiophilic material in vessel
walls). Inclusion criteria were age ≤ 70 years, absence of
focal neurological deficits (e.g., paresis after stroke),
absence of signs for polyneuropathy, available data for
gait, neuropsychological testing, and MRI. All examina-
tions were performed within 2 consecutive days. One
hundred and ninety-two age- and sex-matched healthy
controls were recruited from local staff or by advertise-
ment. In a standardized interview, none of the controls
reported any auditory, vestibular, neurologic, cardiovascu-
lar, or orthopedic disorders. A short physical examination
was performed to exclude impairments in motor and sen-
sory functions, coordination, balance, orientation, and
short-term memory. All study participants had normal or
corrected-to-normal vision. Leg length was measured in
all subjects to be used as covariable in the statistical anal-
ysis. The study was performed in accordance with the
Declaration of Helsinki and approved by the local ethics
committee. Written informed consent was obtained from
all subjects.
Quantitative gait assessment
Spatiotemporal gait performance was assessed using the
electronic, pressure-sensitive GAITRite carpet (CIR Sys-
tems, Havertown, USA) with a length of 670 cm and a
sampling rate of 120 Hz. It was recorded under four dif-
ferent conditions similar to previously used experimental
protocols.13,17,18,23 Four trials were performed in each
condition to increase the number of recorded gait cycles
and thereby improving the reliability of gait parame-
ters.24,25 In the first condition, subjects were asked to
walk over the carpet with preferred speed (condition 1,
single task). In the remaining three conditions, subjects
were asked to perform dual tasks. In the first dual task
condition, subjects performed a calculatory cognitive task
while walking (condition 2, calculatory dual task), that is,
serial 7 task. Using this task, we tested the effect of a sec-
ondary, working memory task on gait.26 Next, subjects
performed a semantic cognitive task while walking (con-
dition 3, semantic dual task), that is, a verbal fluency
task. This task was used to test the effect of a semantic
memory task on gait.27 Finally, subjects performed a
motoric, control task while walking (condition 4, motoric
dual task), that is, carrying an empty tray. Subjects were
asked to prioritize the secondary task during walking.
Each walk was started 150 cm in front of the carpet
and continued for 150 cm beyond it in order to record
steady-state locomotion. Gait parameters were recorded
as the mean of the four trials within each condition. We
selected eight gait parameters that have been reported to
correlate with cognitive deficits8 and/or neuroimaging
aspects of SVD.28 These parameters can be assigned to
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three different domains.19 Parameters assigned to the pace
domain were (1) velocity (cm/s), (2) cadence (steps/min),
and (3) stride length (cm). Parameters assigned to the
rhythm domain were (4) double support phase (% of gait
cycle when both feet simultaneously have ground contact)
and (5) swing phase (% of gait cycle when one foot is in
the air). Parameters assigned to the variability domain
were (6) stride time variability (%), (7) stride length vari-
ability (%), and (8) base of support variability (%). Vari-
ability was calculated as the coefficient of variation in
percentage (CV = [standard deviation of parameter/mean
of parameter] 9 100). It represents the magnitude of
stride-to-stride fluctuations within one gait parameter,
with less variability suggesting higher gait automaticity
and stability.29 All gait parameters were calculated with
respect to the left leg side.
For analysis, we used single task walking performance
and dual task costs, that is, the relative difference between
dual task walking and single task walking (dual task costs
= ([dual task walking – single task walking]/single task
walking) 9 100). We assessed dual task costs in order to
examine performance alterations under dual task walking
in relation to single task walking.
Gait parameters in the single task and dual task costs
were standardized. We transformed raw data into z-scores
by calculating means and standard deviations of 192
healthy controls (tested with the same gait protocol at
our institution) separately for males and females in age
ranges of 20–39, 40–59, and 60–79 years. We used z-
scores as an intuitive measure for effect size of differences
between CADASIL patients and healthy controls. Negative
z-values represent worse performance compared to con-
trols. A z-value of 0 represents no difference between
CADASIL patients and controls, that is, norm perfor-
mance.
Neuropsychological assessment
The Trail Making Test (TMT) is a paper–pencil test on
executive functions, specifically mental flexibility and
processing speed.30 In TMT matrix A, participants are
asked to connect numbers presented at different loca-
tions on the sheet of paper from 1 to 25 in increasing
order as quickly as possible. In TMT matrix B, numbers
and letters have to be connected alternately in increasing
order. TMT raw test scores were transformed into age-
and education-corrected z-scores based on normative
data from the literature.31 We prespecified processing
speed for cognitive function analysis, because it is the
most prominently and often only affected cognitive
domain in SVD.32 More specifically, we used a previ-
ously established compound score of processing speed
(mean z-score of TMT A and B), which has been shown
to highly correlate with white matter alterations in
SVD.33–35
Magnetic resonance imaging
MRI scans of all CADASIL patients were acquired on a
single 3.0T Magnetom Verio scanner (Siemens Healthi-
neers, Erlangen, Germany). The MRI protocol included
1 mm isotropic 3D-T1, 1 mm isotropic 3D fluid-attenu-
ated inversion recovery (FLAIR), 2D-T2 and diffusion
MRI sequences (30 diffusion directions; b-value 1000 sec/
mm2, 2 mm isotropic). Complete details on sequence
parameters have been described previously.36
The following SVD lesions were quantified according
to the STRIVE consensus criteria37 to enable a better
interpretation of sample characteristics: WMH volume,
lacune volume, and brain volume. Processing pipelines
have been described previously.33,38 All volumes were nor-
malized for head size by the intracranial volume.
Diffusion tensor imaging
We used DTI to study the effect of white matter alter-
ations on gait. DTI is a sensitive technique to characterize
white matter microstructure by quantifying water diffu-
sion in brain tissue.39 In SVD, the magnitude of diffusion
in brain tissue is increased (increase in mean diffusivity,
MD). To extract DTI measures, we performed the follow-
ing processing steps:
After visual inspection to exclude major artifacts, diffu-
sion data were preprocessed using MRtrix v3.0 package
(http://www.mrtrix.org) and the Functional Magnetic
Resonance Imaging of the Brain software library (FSL),
v5.0.10.40 After noise and Gibbs ringing artifacts removal
(“dwidenoise,”41 “mrdegibbs”;42 MRtrix), images were
corrected for subject motion and eddy-currents
(“eddy_correct”; FSL). Diffusion tensors and scalar diffu-
sion measures were estimated using “dtifit” (FSL).
We analyzed the effect of both global and regional
white matter alterations on gait.
As a global measure for SVD-related white matter alter-
ations, we calculated the peak width of skeletonized mean
diffusivity (PSMD).35 PSMD is a fully automated SVD
burden marker and sensitively captures global alterations
in white matter integrity. We prespecified PSMD as a
marker for global white matter alterations, because it
highly correlates with processing speed33,34 and outper-
forms other MRI-based markers (such as WMH volume,
lacune volume, and brain volume) in explaining clinical
deficits.35 PSMD was calculated with a publicly available
script (http://www.psmd-marker.com).
To analyze regional white matter alterations, we calcu-
lated voxel-wise MD values within major white matter
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tracts. We used the tract-based spatial statistics (TBSS)
pipeline43 within FSL with standard parameters and a
fractional anisotropy standard template in Montreal Neu-
rological Institute (MNI) space, provided by FSL. Rigor-
ous checks were performed at each step of the pipeline.
Finally, a custom mask was applied to exclude regions
close to cerebrospinal fluid in order to avoid partial vol-
ume effects.
Statistical analyses
Statistical analyses were performed in R (v3.4.1).44
Wilcoxon signed-rank tests against zero were used to
examine whether z-scores (representing differences
between CADASIL and healthy controls) were signifi-
cantly different from zero, that is, from norm perfor-
mance. We used nonparametric testing due to presence of
nonnormally distributed values in patients.
The association between processing speed or global
white matter alterations (assessed by PSMD) and gait per-
formance was evaluated by multiple, linear regression
models corrected for patients’ leg lengths. Gait parameters
were used as dependent variables. Gait parameters, pro-
cessing speed scores, and PSMD values were power trans-
formed in case of nonnormal distribution.
P-values of multiple regressions and Wilcoxon signed-
rank tests against zero were Bonferroni-corrected. Statisti-
cal significance level was set at acorr. < 0.05.
Regional associations between white matter alterations
(voxel-wise MD values as independent variables) and gait
parameters (dependent variables) were performed using
permutation test theory with a standard general linear
model (“randomise”; FSL). All linear models were cor-
rected for leg length. The number of permutations was
set at 5000. Significant voxels within the skeletonized MD
maps were identified using threshold-free cluster enhance-
ment with P < 0.05, corrected for multiple comparisons.
Results
Sample characteristics
Sample characteristics are provided in Table 1. CADASIL
patients showed a high WMH lesion load (Fig. 1). Raw
values of single task gait performance and dual task costs
for CADASIL patients as well as for healthy controls are
depicted in Table 2.
Moderate single task gait changes in the
rhythm domain
Figure 2 shows the gait profile of CADASIL patients during
single task walking. CADASIL patients performed worse
than controls in the rhythm domain, that is, prolonged
double support (z-score median = 1.00; Pcorr =
2.9 9 107) and shorter swing phase (z-score
median = 0.94; Pcorr. = 7.4 9 109). Of note, effect sizes
were only modest with about one standard deviation.
Other domains than the rhythm domain were not affected.
Moderate increase in semantic dual task
costs in the rhythm and pace domain
The effects of the calculatory, semantic, and motoric task
on gait performance were assessed by dual task costs
(Fig. 3). Gait performance was predominantly changed by
the semantic task. More specifically, semantic dual task
walking pronounced deficits in the rhythm domain,
which had already been affected in single task walking
(i.e., prolonged double support, z-score median = 0.27;
Pcorr. = 0.002, and swing phase, z-score median = 0.34;
Pcorr. = 0.005). In addition, the semantic task uncovered
deficits in the pace domain (i.e., reduced gait velocity, z-
Table 1. Sample characteristics.
CADASIL n = 39
Demographic characteristics
Age, years
mean (SD) [min, max]
50.0 (8.1)
[32.0, 62.0]
Education, years, mean (SD) 10.8 (1.6)
Female, No. [%] 27 [69]
Cognitive scores
TMT-A1,
median (IQR) [min, max]
0.22 (1.31)
[8.62, 1.29]
TMT-B1,
median (IQR) [min, max]
0.43* (2.58)
[12.66, 1.72]
Processing speed1,
median (IQR) [min, max]
0.55** (2.06)
[10.64, 1.36]
Verbal fluency1,
median (IQR) [min, max]
0.20 (1.39)
[1.83, 2.61]
MMSE,
median (IQR) [min, max]
30 (1)
[27, 30]
Imaging characteristics
PSMD, 104 mm2/sec
median (IQR) [min, max]
4.54 (2.32)
[2.67, 9.21]
Normalized WMHV, %,
median (IQR) [min, max]
4.40 (6.04)
[0.09, 22.84]
Normalized LV, %,
median (IQR) [min, max]
0.01 (0.06)
[0.00, 0.25]
BPF,
median (IQR) [min, max]
0.80 (0.06)
[0.70, 0.87]
BPF, brain parenchymal fraction; IQR, interquartile range; LV, lacune
volume; MMSE, Mini-Mental State Examination; PSMD, peak width of
skeletonized mean diffusivity; TMT, Trail Making Test; WMHV, white
matter hyperintensity volume.
1Age- and education-adjusted z-scores.
**Pcorr. < 0.01
*Pcorr. < 0.05; Wilcoxon signed-rank tests against zero.
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score median = 0.88; Pcorr. = 2.2 9 105, cadence, z-
score median = 0.46; Pcorr. = 0.002, and stride length,
z-score median = 0.80; Pcorr. = 3.3 9 104). The calcu-
latory task affected swing phase only (z-score
median = 0.42; Pcorr. = 0.020). Again, effect sizes for
dual task worsening were only moderate (less than one
standard deviation of the performance in healthy subjects).
We did not find a dual-tasking effect in the variability
domain.
As expected, the motoric task, which has been used as
a control task, did not worsen gait.
Processing speed is not related to single
task walking or dual task costs
Compared with healthy controls, CADASIL patients per-
formed significantly worse in speed-dependent cognitive
tests (Table 1). Also, processing speed was significantly
associated with global white matter alterations (PSMD)
(b = 0.78, R2adj. = 15.3 %; Pcorr. = 0.008). To investi-
gate whether processing speed impacts on gait perfor-
mance, we examined associations with single task walking
or dual task costs. There was no significant association
with any single task parameter or dual task costs (all
Puncorr. > 0.051, all Pcorr. > 0.410).
Global white matter alterations are
associated with single task stride length
Finally, we examined the impact of SVD-related white
matter alterations on gait performance. First, we assessed
the relationship between global white matter alteration
(PSMD) and gait parameters. In the single task, higher
PSMD was associated with shorter stride length (i.e.,
b = 0.21, R2adj. = 18.0 %; Pcorr. = 0.030) (Table S1).
The association between PSMD and single task velocity
was marginally significant (b = 0.18, R2adj. = 13.7 %;
Pcorr. = 0.090). There was no association with any other
single task parameter or dual task costs (all
Pcorr. > 0.220).
Regional effects of white matter alterations (MD) on
gait performance were assessed using voxel-wise regres-
sion analyses. Higher MD values in the entire white mat-
ter skeleton were associated with shorter stride length and
slower gait velocity in the single task (Fig. 4). Infratento-
rial white matter regions did not show significant voxels.
Significant associations were also found for single task
cadence, double support, stride time variability, and stride
length variability. For these gait parameters, instead of the
entire skeleton being significant, we found smaller signifi-
cant clusters (Fig. 4). Still, for these smaller clusters there
was no clear preference for specific white matter tracts, as
individual clusters were distributed over the entire white
matter. No significant voxels were found for swing phase
or base of support. Importantly, similar to the global
analysis using PSMD, no significant regional associations
were found for dual task costs.
Discussion
We investigated the effect of pure, genetically defined SVD
on gait while walking only (single task walking) and while
performing a secondary cognitive or motoric task (dual
task walking). We found that (1) despite severe brain
lesions, single task gait performance in CADASIL patients
was relatively preserved, with minor deficits only in the
rhythm domain. (2) The semantic dual task aggravated gait
rhythm deficits and uncovered pace deficits. (3) Cognitive
impairment, that is, processing speed deficits, in pure SVD
did not worsen gait and (4) global white matter alterations
affected single task stride length only.
Gait performance of pure SVD patients with severe
white matter alterations differed only slightly from that of
healthy controls, more precisely around one standard
deviation in the rhythm domain. Dual task walking,
which has been used to uncover or pronounce gait defi-
cits3 caused a moderate deterioration of the rhythm fea-
tures and unmasked gait abnormalities in the pace
domain that were not present during single task walking.
Interestingly, we did not find an association between cog-
nitive performance (i.e., processing speed) during neu-
ropsychological testing and gait performance in our
sample. Our results thus suggest that severe SVD alone
and its effect on cognition might only play a minor role
Figure 1. White matter hyperintensities in pure SVD. White matter
hyperintensities on fluid-attenuated inversion recovery (FLAIR) images.
(A) Subject with median lesion load. (B) Lesion frequency map
superimposed onto the Montreal Neurological Institute 152 standard
brain template. L = left.
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in causing gait impairment. In elderly, sporadic SVD
patients, the combination with other age-related patholo-
gies might be decisive for gait decline. One might specu-
late that joint problems, sarcopenia, and reduced sensory
input3 are therefore more promising targets for preven-
tion and rehabilitation of gait deficits in the elderly. For
instance, treatment for sarcopenia could include physical
exercise, balance training, and protein supplementation to
support muscle gain.45
Affected gait domains in pure SVD
Although only moderate, differences in gait performance
between pure SVD patients and healthy controls were
detectable in the rhythm domain while single task walk-
ing. Changes in gait rhythm indicate difficulties in keep-
ing balance and have been shown to correlate with SVD
markers, like WMH.4
Semantic dual-tasking pronounced gait deficits in the
rhythm domain and additionally uncovered deficits in the
pace domain, suggesting that brain networks that control
rhythm and pace are interlinked with networks for the
performance of the verbal fluency task. Control of gait
rhythm and pace and the semantic task seem to compete
for the same cognitive resources resulting in higher dual
task costs. This is in line with previous studies showing
that verbal fluency dual tasks resulted in reduction in gait
velocity in community-dwelling older adults,5 in individu-
als with MCI and Alzheimer’s disease dementia.18
However, we did not find an effect of single or dual
task walking on the variability domain in pure SVD
patients indicating steady gait performance in all condi-
tions. Gait variability has been described as a sensitive
marker of dynamic gait stability and is an established
parameter in fall risk assessment.17 It seems that our sam-
ple of pure SVD patients was able to engage enough cog-
nitive resources to compensate increasing variability from
stride-to-stride, even while cognitive dual-tasking.
Ultimately, comparing affected gait domains or vari-
ables between studies with different cohorts is difficult,
not only because of age differences and accompanying
comorbidities in the study samples, but also because of
the number and kind of examined gait variables (i.e., only
velocity in most studies), and differences in secondary
cognitive or motor tasks while walking. An agreement of
standardized dual task methodologies is crucial in future
research to further study gait impairment in SVD or neu-
rodegenerative diseases.
Differential effects of secondary cognitive
tasks
In our sample of relatively young, pure SVD patients, the
semantic (verbal fluency) dual task worsened gait more
Figure 2. Single task walking. Median z-values in CADASIL (solid
black line) and interquartile ranges (gray) for single task walking
parameters. Negative values represent worse performance compared
to healthy controls (dashed norm line). **Pcorr. < 0.01, Wilcoxon
signed-rank tests against zero. CV, coefficient of variation.
Figure 3. Dual task costs. Median z-values (dots) of different dual
task costs in CADASIL patients. Negative values represent higher costs
compared to healthy controls (dashed norm line). **Pcorr. < 0.01,
*Pcorr. < 0.05, (*) Puncorr. < 0.05; Wilcoxon signed-rank tests against
zero; bars depict the 95 % confidence interval. CV, coefficient of
variation.
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Figure 4. Voxel-wise associations between mean diffusivity (MD) and single task walking. Axial slices of the white matter skeleton (green)
superimposed onto the Montreal Neurological Institute 152 standard brain template. Depicted are significant associations (red) after correction for
multiple comparisons. L = left.
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than the calculatory (serial 7) dual task. Some studies
investigated the effect of type and complexity of the sec-
ondary tasks on dual task walking.17,18,23,46 Contrary to
our results, it has been shown that the serial 7 task gener-
ates greater cognitive load than verbal fluency tasks in
frail, older adults and subjects with MCI and Alzheimer’s
disease, resulting in worse gait performance in the calcu-
latory than the semantic task. A possible explanation for
this difference with previous studies might be the typical
cognitive profile in SVD, with deficits predominantly in
processing speed. Verbal fluency is a semantic memory
task imposing substantial demands upon processing speed
during retrieval from semantic long-term memory.
Effect of processing speed on gait
Other than expected, we did not find an association
between processing speed deficits and single task gait or
dual task costs in pure SVD. Cognitive deficits, beside
white matter alterations, are thought to be an important
factor for gait disturbances, for example, as shown in frail
older adults, individuals with MCI, and demented
patients while single task and dual task walk-
ing.13,14,17,18,47–49 Yet, the effect of cognitive impairment
on single and dual task gait has not been examined
specifically in SVD. Our results in pure SVD patients sug-
gest that cognitive deficits related to SVD do not worsen
gait. Of note, none of our subjects was demented and
thus we cannot exclude a detrimental effect of cognition
on gait in late disease stages. Generalizability of existing
study results about the relation between cognition and
gait is limited, as tests used to measure processing speed
or executive function vary between studies. Also, exam-
ined samples are considerably older than ours and the
presence of age-related pathologies was not always sys-
tematically assessed or excluded. The possibility remains
that in previous studies associations between cognitive
deficits and gait were at least in part driven by age-related
comorbidities.
Effect of white matter alterations on gait
Correlation analyses revealed significant associations
between SVD-related white matter alterations measured
by DTI and reduced stride length and marginally veloc-
ity in pure SVD patients. The same parameters were
affected in sporadic SVD patients with strategic brain
lesions related to gait deficits.6,9 Using the voxel-wise
analysis, we found no indication for regional effects or
spatial heterogeneity. Instead, we found a rather global
effect of supratentorial white matter alterations on pace
parameters, that is, on stride length and velocity, but
not on cadence. In line with a study by de Laat and
colleagues,6 only few voxels with higher MD were related
to a lower cadence, suggesting that the control of
cadence is less affected by white matter alterations than
other pace parameters. Thus, white matter alterations
might predominantly influence spatial characteristics of
stepping like stride length. Temporal pace maker regions
in the locomotor network, such as the cerebellar loco-
motor regions, do not appear to be affected in pure
SVD.
Limitations
Some limitations need to be considered. First, we did not
obtain MRI in our control group, therefore subclinical
SVD cannot be excluded in our clinically healthy sample.
Second, while the examination of eight different spa-
tiotemporal gait variables allowed precise description of
gait performance, correcting for multiple comparisons is
accompanied by a loss of statistical power. Third, our
results are based on cross-sectional data, which do not
allow to draw conclusions on causality. While our sample
of pure SVD patients was relatively small, it enabled to
detect subtle differences between groups and provided the
unique opportunity to study the effects of pure SVD.
Conclusion
Despite severe brain lesions in genetically defined, pure
SVD patients, gait performance was relatively preserved.
Differences between pure SVD patients and healthy con-
trols in single task walking and dual task costs were only
moderate. Neither processing speed performance nor
white matter alterations were associated with dual task
costs. We speculate that other age-related morbidities
affecting the brain or other relevant organ systems, such
as neurodegeneration, pharmacotherapy, sarcopenia, mus-
culoskeletal disease, or polyneuropathy contribute toward
gait impairment in elderly people. These factors should be
considered in future research, as well as in new strategies
for intervention and rehabilitation.
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